Zelira Therapeutics Limited

ZLDAF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$1-$2-$2-$34
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0-$1$0$0
Change in WC$0$0$0$0
Other Non-Cash-$1$1-$0$32
Operating Cash Flow-$2-$3-$3-$2
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$1$0$1$0
Investing Cash Flow$1$0$1$0
Financing Activities
Debt Repay.$0$2$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$2$2
Financing Cash Flow$1$2$2$2
Forex Effect-$0-$0-$0-$0
Net Chg. in Cash-$0$0$1-$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$0$0$1$0
Free Cash Flow-$2-$3-$3-$2
Zelira Therapeutics Limited (ZLDAF) Financial Statements & Key Stats | AlphaPilot